Delve Bio - Crunchbase Company Profile & Funding

Q: Who invested in Delve Bio?

Delve Bio has 3 investors including S32 And Google Ventures.

Q: When was the last funding round for Delve Bio?

Delve Bio closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Delve Bio raised to date?

Delve Bio has raised obfuscated.

Overview

Delve Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+3 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Delve Bio

CB Rank

18361

Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.

Founded

obfuscation

Private

Series A

San Francisco, California, United States

11-50

www.delve.bio

Biotechnology

Health Care

Funding Rounds

Series A

OBF

obfuscation

Key People

Joe DeRisi: Co-Founder
Bradley Murray: CEO and Co-Founder

Details

Legal Name

Delve Bio, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Bradley Murray, Charles Chiu, Joe DeRisi, Matthew Meyerson

About the Company

Delve Bio is a biotechnology business that provides molecular insights for patient precision care. Delve Bio is a biotechnology business that aims to give molecular insights for precision patient care.

Predictions & Insights

Growth Insight

See this Growth Insight

Delve Bio is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

Delve Detect

A metagenomic next-generation sequencing test that identifies bacteria, viruses, fungi, and parasites from cerebrospinal fluid samples within two days.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A
obfuscated obfuscation	Series A - Delve Bio	3	obfuscated obfuscation	Xontogeny	Series A